Saisei Pharma
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Trial Efficacy of Saisei Pharma Dietary Supplements MAF Capsules, 148 mg and M Capsules, 148 mg in Hospitalized COVID-19 Patients (NCT04762628) | Saisei Pharma | 2020-10-27 |
Track Saisei Pharma automatically
Every clearance here is in the API, with alerts when new ones post.